• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Genetically transformed, non-tumorous plant cells. A modified Ti plasmid is created which contains a left T-DNA border, one or more desired genes, and a right T-DNA border. This region does not contain tumorigenic or phytohormone-altering genes. The Ti plasmid is inserted into plant cells, where the T-DNA region is transferred into the plant genome. The transformed plant cells may be regenerated into morphologically normal plants which will pass the desired gene(s) to their descendants.
    公开号:SU1582990A3
    申请号:SU843701787
    申请日:1984-01-16
    公开日:1990-07-30
    发明作者:Томас Фралей Роберт；Брус Хорш Роберт；Гэри Роджерс Стивн
    申请人:Монсанто Компани (Фирма)；
    IPC主号:
    专利说明:

    one
    (21) 3701787 / 30-13
    (22) 1/16/84
    (31) 458402
    (32) 1/17/83
    (33) US
    (46) 07/30/90. Bul Number 28
    (71) Monsanto Company (US)
    (72) Robert Thomas Fralay, Robert Bruce Horsch, Steven Gary Rogers (US)
    (53) 575,224.2: 577.2 (088.8)
    (56) Ti plasmids and Directed Genetic Engineering Molecular Biology of Plant Pumor, ed. G Kahl and G.S. Schell, 1982, p. 537-548.
    (54) METHOD FOR OBTAINING TRANSFORMED CELLS OF DOUBLE PLANTS
    (57) The invention relates to biotechnology, in particular to genetic engineering of plants. The aim of the invention is to increase the yield of normal transformed plant cells. The method consists in constructing plasmids pMOK 41, pMON 113, pMON 109, splitting them with endonucleases to form target fragments, ligating the fragments obtained to form an intermediate vector pMON 120. Plasmid pMON 128 (or any other plasmid obtained by inserting the PMON120 chimeric gene is introduced into Agrobacterium tumefaciens containing Ti plasmids. Integrative plasmids are transferred into plant cells, selected transformed plants flax cells and trans-transformants are grown on medium before growth is formed.
    with
    SS
    (/)
    This invention relates to biotechnology, in particular to genetic engineering of plants.
    The aim of the invention is to increase the yield of normal transformed. plant cells.
    A number of plasmids are constructed.
    pMON 41, with the right Ti edge of a nopaline type plasmid and the 5th region of the nopaline syntase (NOS) gene, pMON l09 with the 3th region of the NOS gene, and a selectable marker gene (Spc / Str) that allows selection of A. tumefaciens cells containing coin - Tegrative Ti plasmids with chimerical genes, pMON 113, with a DNA segment whose sequence is identical to the sequence in the T-DNA region of the Ti plasmid of the octopin type.
    Each plasmid was digested with endonucleases to obtain the target fragment. The resulting fragments are ligated and an intermediate vector PMON 120 is obtained.
    Plasmid pMON 120 has the following characteristics.
    It has three unique restriction sites (Eco RI, Cla I, Hind III), replicates in normal E. coli cells. However, it does not replicate in normal Agrobacterium cells without cointegration with another plasmid, for example, a Ti plasmid that replicates in Agrobacterium cells.

    ABOUT
    Carries a marker gene that has a cognate enzyme that confers resistance to two antibiotics, spectinomycin (Spc) and streptomycin (Str). This gene, called the Spc / Str gene, is expressed in E. and A. tumecaciena, but not in plant cells, does not carry genes that encode ampicillin or tetra-cyclin resistance.
    Contains a sequence that is homologous to the sequence in the region of the T-DNA of the octo-type Ti Gshazmida. Ao tumefaciens. This sequence is called the left internal homologous (LIH) region. This region of homology promotes a cross act, as a result of which pMON 120 or such a derivative of pMON 120, as pMON 128, forms a cointegrate with the TЈ plasmid if both Plasmids exist within the same A. tumefaciens cells. By definition, a cointegrating plasmid is formed by a simple cross act. It contains all the DNA sequences that previously existed either in the Ti plasmid or in the plasmid obtained from pMON 120.
    Contains the right extreme portion of the T-DNA of the nopaline type a sequence that can function as one end (for convenience, denoted as the right edge)
    to
    15
    20
    25
    thirty
    Hind III is cleaved by endonuclease to obtain various fragments, including a fragment of 3.4 thousand in size, which is designated as the Hind 111-23 fragment. This fragment contains the entire NOS gene and the rightmost region of T-DNA. The Hind III-23 fragment is inserted into the pBR 327 plasmid. The resulting plasmid is designated pNOM 38 and is cleaved. As a result, a fragment of 2.3 thousand bases is obtained which contains the rightmost part of the nopaline type and the 5th section of the NOS gene (including the promoter region , 5-untranslated region and part of the structural sequence This fragment, with a size of 2.3 thousand bases, is included in the plasmid pBR 327, which is cleaved in advance by Hind III and Bam HI. The resulting plasmid is designated pmon 41.
    Plasmid pMON 109 includes the Spc / St selectable marker gene and 3 parts of the NOS gene up to pMOM 120. It is constructed as follows.
    Plasmid pMON 38 cleaves Rsa I, resulting in blunt ends, as indicated: 5-C TAG, CAT G,
    A fragment of 1.1 ti of base is isolated and Bam HI is cleaved to obtain fragments of size 720 and 400 base pairs, each of which has one blunt Rsa end and sticky Bam HI end. These fragments add T-DNA sequences that are passed to double-stranded DNA from phage M13 tr8,
    rendered from a plasmid Ti and incorporated into the chromosome of a plant cell during cell transformation using A. tumefaciens.
    which splits Stna I (which gives blunt ends) and Bam HI. The resulting mixture is ligated, transformed into cells, Recombinant DNA phages that carry the gene (including the promoter), which contain a fragment of
    ry encodes the expression of the enzyme, nopalinsin tazy (NOS). When introduced into the plant cell NOS, the enzyme catalyzes the production of nopalin, such as opin, 4
    A part of the cointegrative Ti plasmid (modified T-DNA region) is inserted into the plant genome, i.e. only a portion of the plasmid obtained from pMON 120 includes the fe plant genome. 5 This portion starts from the outermost T-DNA region and extends in one direction only to the homology region.
    The size of the plasmid pMON 120 is about 8 thousand bases.
    Nopaline type Ti plasmid, designated as pTi 137 plasmid,
    o
    five
    0
    five
    0
    digested with Hind III by endonuclease to obtain various fragments, including a fragment of 3.4 thousand in size, which is designated as the Hind 111-23 fragment. This fragment contains the entire NOS gene and the rightmost portion of the T-DNA. The Hind III-23 fragment is inserted into the plasmid pBR 327. The resulting plasmid is designated pNOM 38 and is cleaved. As a result, a fragment of 2.3 thousand bases is obtained, which contains the nopaline right end runoff and the 5th section of the NOS gene (including the promoter region, 5-untranslated plot and part of the structural sequence). This fragment of 2.3 thousand bases is included in the plasmid pBR 327, which is cleaved in advance by Hind III and Bam HI. The resulting plasmid is designated pMOH 41.
    Plasmid pMON 109 includes the Spc / Str selectable marker gene and 3 region of the NOS gene up to pMOM 120. It is constructed as follows.
    Plasmid pMON 38 cleaves Rsa I, resulting in blunt ends, as indicated: 5-C TAG, CAT G,
    A fragment of 1.1 thousand bases was isolated and split with Bam HI to obtain fragments of 720 and 400 base pairs, each of which has one blunt Rsa end and sticky Bam HI end. These fragments are added 5 to double-stranded DNA from phage M13 tr8,
    which splits Stna I (which gives blunt ends) and Bam HI. The resulting mixture is ligated, transformed into cells, Recombinant DNA phages that contain a fragment of size
    720 pairs, identify by size. Bam HI-Sma 1 „inserts
    One of these phages is designated as M-4. A fragment of 720 base pairs contains a 3-untranslated region (including a poly-adenylation signal) of the NOS gene and the 3rd segment of the structural sequence of the NOS gene. A fragment of 720 base pairs is surrounded in M-4 Eco RI and Pst I by cleavage sites are present in M13 shr8 DNA.
    The bacterial transposon, TP 7, is known to contain the Spc / Str gene mentioned earlier. TP 7 transposon also contains a gene that causes resistance to the antibiotic trimethoprim in host cells. The exact location and orientation of the Spc / Str gene and the gene for resistance to trimethoprim in TP 7 is unknown. Transposon TP 7 was isolated from the A. tumefaciens strain, in which TP 7 was included in the Hind III-23 region of the pTi T37 plasmid,
    The plagmid pGV 3106 was digested with Hind III and the fragments were cloned into pBR 327 of the plasmid digested with Hind III; The resulting plasmids include
    E, coli cells, select cells that were resistant to ampicillin (thanks to the pBR 327 gene) and resistant to trimethoprim (thanks to the Tp 7 gene). A plasmid derived from a single colony is designated pMON 31. This plasmid contains an insert of 6 thousand Hind III bases. The insert contained the Spc / Str gene - resistance and the gene for resistance to trimethoprim from Tn 7, and the 3rd part of the NOS gene (which came from the pTi T37 plasmid).
    The size of the plasmid pMON 31 is reduced twice. First, the size reduction is performed by digesting the Eco P.I plasmid, removing the fragment with a size of 850 base pairs and re-linking the large fragment. The resulting plasmid is designated as pMOK 53, isolated from transformed cells selected for their resistance to ampicillin and streptomycin. Trimethoprim resistance was not determined. The size of plasmid pMON 53 was reduced by splitting the plasmid Cla I and removing a fragment with a size of 2 thousand base pairs and stitching again a large fragment. The resulting plasmid with a size of 5.2 thousand bases is designated as pMON. This plasmid contains the Spc / Str gene.
    Plasmid pMON 54 was cleaved with Eco RI and Pst I and a fragment of 4.8 thousand bases was isolated containing the Spc / Str gene. M-4 DNAs are cleaved with Eco RI and Pst I and a 740 base pair fragment containing the NOS untranslated region is isolated. These fragments are stitched together prior to the formation of pMON 64. A plasmid with the desired orientation is identified by splitting Eco RI and Bam HI. They are designated as pMON 109.
    Plasmid pMON 113 contains a region of homology with pMON 120, which allows pMON 120 to form a cointegrative plasmid, if present in A, tumefaciens along with
    o
    five
    0
    Ti plasmid. Plot homology chosen from the Ti plasmid octopic - type. 3 Ti plasmid, it is located near the left T-DNA of the outermost region, inside the T-DNA region of the Ti plasmid. This region of homology is designated as the left inner region of homology (LIH).
    The homology region is obtained from any type of plasmid capable of transforming plant cells. An intermediate vector is constructed that can form a cointegrative plasmid with the type of plasmid from which the homologous region was obtained.
    E. coli culture is obtained with a pBR derivative of a plasmid containing the Wat-8 Ti fragment of the octopine type plasmid. The Wat-8 fragment with a size of 7.5 thousand bases contains the left extreme region and the LIH segment of the plasmid Ti. Wat-8 fragment include in
    plasmid pBR 327, which is digested with Bam HI.
    Plasmid pMON 90 is cleaved with Bgl II and a fragment of 2.6 thousand bases, which contains the LIH section, but
    0 does not contain the leftmost region, are highlighted. A 2.6 thousand fragment of the bases was treated with Klenow polymerase to convert sticky ends into blunt ends and the resulting fragment
    C is cleaved with Hind III to obtain a fragment with a size of 1.6 thousand bases (target fragment) and a fragment with a size of 1 thousand bases. Both fragments are mixed with pBR 322 plasmid, which
    0, Pvn II and Hind III are cleaved in advance. The resulting mixture is mixed and incorporated into E. coli cells. Cells are selected for ampicillin resistance and a search is carried out on the Sma J site, which is
    5 in the fragment with a size of 1.6 thousand bases and which is not in the fragment with a measure of 1 thousand bases. The colony with the target plasmid is identified and the plasm of the MIDU from this colony is designated
    0 PMCN 113,
    Plasmid pMON 41 was cleaved with Pvn I and Wat I and a fragment of 1.5 thousand bases was isolated, containing the right edge of the nopaline type and 5 the NOS gene. The pMON 109 plasmid was digested with Bam HI and Eco RI, and a fragment of 3.4 thousand bases was isolated containing the Spc / st gene and the H1 portion of the NOS gene, the Plaemid pMON 113 was cleaved with Pvn I and Eco RI
    and isolating a 3.1 kb fragment containing the LIH region.
    These three fragments are mixed together and stitched prior to the formation of pMOM 120. The bacterial culture E "coli, containing pMON 120, is deposited in the American Type Culture Collection under No. 39263,
    Method of application pMO 120.
    The pMOM 120 plasmid has three unique cleavage sites (Eco RI, Cla I, and Hind III) that are suitable for including any desired gene. These cleavage sites are located in the region of pMOM 120, which must be included in the plant genome, so that the included gene will also be included in the plant genome.
    Various chimeric genes are constructed that are capable of expressing .bacterial p olipspptides and polypeptide mammals in plant cells.
    A chimeric gene is constructed that (includes the following DNA sequences,
    Promoter region and 5 non-translated region, derived from the nopaline synthase gene (MOS), Structural sequence, derived from the neomycin phosphotransferase II gene (NPT II). 3 untranslated region, derived from the NOS gene.
    This chimeric NOS-NPT II-NOS gene is isolated on a DNA fragment containing Eco RI ends. It is included in the Eco RI site of the plasmid pMCN 120 and the resulting plasmids (with oppositely oriented chimeric gene inserts) are designated pMON 128 and pMON 129 Plasmid 129 has two copies of the chimeric gene. Each plasmid is used. are used to transform plant cells. E. coli culture, containing pMON 128, is deposited in the American Type Culture Collection. A registration has been assigned to this culture.
    number 39264. i
    The pMON 128 plasmid (or any other plasmid obtained by inserting the target gene into pMON 120) is introduced into a microorganism that contains an octopine type plasmid Ti (or other suitable plasmid). Suitable microorganisms include A, tume- fiens and A, rhirogenes, which contain Ti. or Hi plasmids.
    The plasmid is inserted into the transformation microorganism or conjugated to the cell.
    five
    0
    five
    0
    five
    0
    five
    0
    five
    Kami that contain pMON 128 or other plasmids, Plasmid, such as pMON 128 has a region that is homologous to the sequence in the Ti plasmid. This LIH homology portion allows for a single cross-over act, whereby the pMSM 128 and the Ti plasmid of the octopin type are combined to form a coinitictive plasmid. This usually happens with cell A, tumefaciens after pMON 128 is inserted into the cell. In another embodiment, a co-integrative plasmid is created in a cell of another type or in vitro, incorporated into A. tumefaciens or another cell type that is capable of transferring the cointegrative plasmid into plant cells.
    Plasmid, such as yoke 128, combined with the Ti plasmid to obtain plasmid kointegrativnoy 6 Culture A. tumefaciens GV 3111 containing plasmid kointegrativnuyu obtained from the yoke 128 and the Ti plasmid wild-type pTi B653, deposited at the American Type Culture Collection and assigned registration number 39266,
    If a co-integrative Ti plasmid is incorporated into a plant cell, then either of the two DNA strands can be entered into the plant genome, region 14 or T-DNA 16,
    An alternative method is developed in which the need to separate tumor cells from non-tumor cells is avoided. Some mutant strains A, tumefaciens, which are unable to cause the disease of the apical gall tumor, are isolated. Such strains are usually called unarmed Ti plasmids. Ti or Ri plasmids can be disarmed by one or more types of mutations.
    After pROM128 cells are inserted into A. tumefaciens, the desired crossing will occur in certain parts of the cell. Cells that contain cointegrative plasmids (regardless of whether they are virulent or disarmed) are selected from other cells in which crossing does not occur, as follows. The pMOM 120 plasmid and its derivatives contain a marker gene (Spc / str), which is expressed in A. tumefaciens. However, these plasmids do not replicate in A. tu4 mefaciens. Therefore, spc / str marker
    The gene is not inherited stably in A. tumefaciens, unless the included plasmid combines with another plasmid that can replicate in A. tumefaciens. The most likely such combination due to the homologous ™ region is co-integration with the Ti plasmid. A. tumefaciens cells that contain such a cointegrative plasmid are identified and selected when cells are grown on medium containing either Spc, or str, or both.
    It is possible that a co-integrative Ti plasmid undergoes a sequential crossing, in which two L1H regions will be recombined. Such an act is undesirable because it can lead to DNA division between LIH sites containing a chimerical gene. However, this apparently does not lead to serious difficulties for two reasons. First, such an act apparently occurs with a relatively low probability, approximately around. Secondly, the pMOM 120 plasmid and its derivatives are designed in such a way that the selectable marker gene (spc / str) is located in the DNA region, which will be excluded by the act of crossing. Therefore, the selective conditions that are used to identify and. the cultivation of Agrobacterium cells containing cointegrative plasmids must be sufficiently rigid to kill generations of cells that undergo the subsequent crossing, which excludes the chimerical gene from the Ti plasmid.
    Only one of the LIH sites in the co-integrative Ti plasmid will be included in the plant genome.
    This important feature is defined by the construction of the pMOK 120 and it is this one that distinguishes this cointegrating plasmid from the undesirable cointegrating plasmids that were previously obtained - the IF segment; which is located outside the T-DNA extreme regions, will not be included in the plant genome. It . brings at least two important benefits. First, the presence of two T.N. sites included in the plant genome can lead to cross-breeding acts, which will lead to the loss of the included genes — into transformed cells and their progeny. First
    0
    0
    , 5 d
    5 Q „
    five
    0
    ryh, the presence of two sections of DNA homology can significantly complicate attempts to analyze DNA inserts into the plant genome.
    A. tumefaciens cells, which contain co-integrative Ti plasmids with chimerical genes, are identified and isolated. Cointegrative plasmids are incorporated into the plant cells to be transformed, exposed to contact with enzymes that remove the cell walls. This turns plant cells into protoplasts, which are viable cells surrounded by membranes. These enzymes are removed and the protoplasts begin to regenerate the cell wall material. At a suitable time point, A. tumefaciens cells (which contain cointegative Ti plasmids with chimeric genes) are mixed with plant protoplasts. These cells are co-cultivated for a period of time that allows A. tumefaciens to infect plant cells. After an appropriate period of co-culture, A. tumefaciens cells are killed and the growth of plant cells continues.
    Transformed plant cells are selected in various ways, depending on the type of gene (s) that were included in the plant
    genome i
    Example 1. Construction of plasmid pMON 41.
    An E. coli culture containing the pBR 325 plasmid with the Hind III -23 fragment of the pTi T37 inserted at the Hind III site is used. 10 µg of the plasmid from this clone cleaves 10 units. Hind III endonuclease for 1 h at 37 ° C. A fragment of 3.4 thousand bases of Hind III-23 was isolated by adsorption on glass beads after separation from other Hind III fragments by electrophoresis on a 0.8% agarose gel. The selected 3.4 thousand bases of the Hind JII fragment (1.0 μg) are mixed with 1.0 μg of the plasmid pBR 327 DNA, which was previously cleaved with the Hind III endonuclease (2 units, 1 h, 37 C) and alkaline phosphate calf (0.2 units, 1 h, 37 ° C), deproteivized with phenol, precipitated with ethanol and resuspended in 10 μl of TE (10 mM Tris HC1, pH 8 g, 1 mM EDTA). One unit of T4 DNA ligase is added to the fragmented mixture. One unit is defined as a concentration sufficient to produce more than 90% circulation of one microgram of Hind III linearized pBR 327 plasmid for 5 min at 22 ° C. Mixed fragments are placed in a total volume of 15 µl of 25 mM Tris HC1 pH 8, 10 mM MgCl2, 1 mM dithiothreitol, 200 μM spermidine HCl and 0.75 mM ATP (ligase buffer).
    The resulting mixture is incubated at 22 ° C for 3 hours, and then mixed with E, coli C 600 gee A56 cells, which are obtained by transformation by treatment with CaC12. For selection, the transformed cells are spread on ZB plates with solid medium containing ampicillin at 200 µg / ml. After incubation at 3.7 ° C for 16 hours, several hundred clones are obtained. Plasmid mini-preparations were isolated from 24 clones and aliquots of plasmid DNA obtained (0.1 µg) were digested with Hind III.
    in order to demonstrate the presence of 3.4 thousand bases of the Hind III fragment, However, from the plasmids demonstrate the expected structure and designate pMON 38, ....
    DNA was prepared using Triton X-10 lysis and a CsCl gradient, 50 µg MON 38 DNA was digested with Hind III and Bam HI (50., unit each, 2 h, 37 ° C), and Hind Ill-Bam HI fragment 2, 3 thousand bases are excreted. The selected fragment (1 μg) is mixed with 1 μg of the Hind Ill-Bam HI fragment with a size of 2.9 thousand, bases of pBR 327 vector. After ligation (T4 DNA ligase, 2 units) and transformation of E. coli cells, 50 ampicillin-resistant colonies are obtained. DNA from twelve plasmid mini-preparations was cleaved with Hind III and Bam HI to establish the presence of a 2.3 kb fragment. One plasma of the desired structure is selected and designated pMON 41,
    Example 2. Thirty µg of the pHON 38 plasmid was digested with Psa I (30 units, 2 hours, 37 ° C) and 1100 base pairs of Rsal) after separation by agarose gel electrophoresis using a glass bead, Raa I - Rsa I A fragment of 1100 base pairs (1 µg) cleaves 2 units. Your HI endonucleases and Bam HI are inactivated by heat. This DNA is mixed with 0.2 μg of phage M13mp8 RF DNA, which
    0
    five
    five
    0
    0 5
    Sma Bam HI is preliminarily cleaved (2 units each for 1 h, and 0.2 units of calf alkaline phosphatase) After crosslinking with 100 units. T4 DNA ligases and transformations of E. coli J101 cells, transformed cells are mixed with soft agar and plated under conditions that allow
    identify recombinant phage. Twelve cells producing recombinant phages were selected and a mini-preparation of RF plasmids was obtained, RF DNA was cleaved with Wat NG and Sma I to prove the presence of the Rsa I - Bam HI fragment of 720 base pairs. One of the recombinant RF DNA carrying. the desired fragment is designated M13 mr8 M-4.
    Example 3. Twenty µg of the pGV 3106 plasmid was digested with Hind III endonuclease (20 units, 2 hours, 37 ° C) and mixed with 2 µg of pBR 327 digested with Hind III, After ligation (T
    5 DNA ligase, 2 units,) and transformations of E. coli cells, as previously described, receive a single colony resistant to trimethoprim (100 μg / ml) and ampicillin. Processing of plasmid DNA from this cell demonstrates the presence of a Hind III fragment measuring 6 thousand bases. This plasmid is designated pMOM 31,
    Plasmid pMON 31 is cleaved by Eco RI endonuclease (1 unit, 1 h, 37 C), Endonuclease is inactivated by heating (10 min, 70 ° C), the plasmid fragment of 8.5 thousand bases is recycled in the ligation reaction 100 µl (T4 DNA ligase, 1 unit) and used to transform E. coli cells with selection of ampicillin-resistant and streptomycin (25 µg / ml) colonies. A plasmid mini-DNA preparation from six clones was cleaved with Eco RI to determine the loss of the 850 fragment para base. One plasmid, which did not have an Eco RI fragment of 850 base pairs, was designated pMOM 53. This plasmid was introduced into E. coli GM42 dam cells (Balectal, 1979) by the transformation described.
    Plasmid pMOM 53 (0.5 µg) from a mini-preparation obtained from cells was digested with Cla I and recycled in a diluted solution. After transformation of E. coli CM42 cells and selection of ampicillin-resistant and spectinomycin (50 μg / ml) clones,
    five
    fifty colonies. Cleavage of plasmid mini-preparations of DNA from six colonies shows that in all there is no fragment with a size of 2 thousand bases of Cla I. One of these plasmids is designated pMOY 54. Plasmid DNA is obtained.
    Plasmid pMON 54 DNA (20 µg) was cleaved by Eco RI and Pst I endonuclease JQ mi (20 units each, 2 h, 37 C) and a fragment of 4.8 thousand in size was purified on an agarose gel using NA 45,
    The purified te 4 fragment, in thousands of bases (0.5 μg), is mixed with 0.3 μg of a 740 base pair fragment of Eco RI - Pst I obtained from M13mp8 M-4 RF DNA, which is purified using a JQ NA-45 membrane . After ligation (T4 DNA of the ligase, 2 units), transformation of E. coli GM42 dam cells, and selection of cells resistant to spectinomycin, 20 colonies are obtained. Plasmid mini-DNA preparation obtained from 12 clones was cleaved Pst I and Eco RI are used to demonstrate the presence of a fragment of 740 base pairs. One plasmid carrying this fragment is designated pMOM 64. -JQ
    DNA (0.5 µg) pMON 64 is cleaved with Cla I (1 unit, 1 h, 37 ° C), then Cla I is inactivated by heating, and the fragment is re-attached with T4 DNA ligase (1 unit). After transformation and selection of cells that are resistant to spectinomycin, a mini-preparation of 12 colonies is obtained, DNA is digested with Bam HI and Eco RI to determine the orientation of the fragment 2 thousand bases of Cla I, Half of the clones contain the Cla I fragment in reverse orientation than in pMON 64 One of these plasmids is designated pMON 109.
    Example 4, Take the plasmid pNW 31C - 8,29C. The plasmid carries the pTiA6 7.5 thousand bases of the Wat 8 fragment, the Wat-8 fragment is isolated from 50 µg of the Bam HI - split plasmid pNW 31C - 8 290 using the NA-45 membrane. The purified Wat-8 fragment of 7.5 thousand bases (1.0 μg) is mixed with 0.5 μg of pBR 327 vector DNA, which was previously cleaved with the endonuclease Bam HI (2 uO and 0.2 units, alkaline calf phosphatase for 1 h at 37ff C, the mixture obtained is deprotected and resuspended. Mixed fragments are treated with T4 ligase (2 units,), using 35
    40
    55
    Q
    e Q 5 Q
    five
    0
    five
    For transformation into E, coli C600 HESA cells, ampicillin resistant colonies are selected. A mini-preparation for plasmid DNA was isolated from twelve of these clones, the DNA was digested with Bam HI for foro to demonstrate the presence of pBR 327 vectors and Yat-8 fragments of size
    7.5k grounds. One of the plasmids in which both of these fragments were present is designated pMOM 90.
    25 µg of pMON 90 DNA was cleaved with Bgl II (25 units, 2 h, 37 ° C) and the Bgl II fragment with a size of 2.6 thousand bases was purified using an NA-45 membrane. To create blunt ends, the fragment (2 µg) is resuspended in Yumkl 50 mM MaCl, 6.6 mM Tris-HCl pH 8,
    6.6 mM MgCl2 and 0.5 mM dithiothritol (Klenow buffer), 4 deoxynucleoside tri-phosphatases (dATP, dTTP, dCTP and dCTP) are added to the final concentration
    1 mM and add one large unit (Klenow fragment of E. coli DNA polymerase 1. After incubating for 20 min at 22 ° C, Klenow polymerase is inactivated by heating and 10 units of Hind III are added. Hind III cleavage is carried out for 1 at 37 ° C and then the enzyme is heat-inactivated. Add blunt Hind III - Bgl II fragments (1 µg) to 0.25 µg Hind III - Pvu II fragment of 2.2 thousand bases, pBR 322, which is obtained by cleavage of Hind III and Pvu II, and then treatment with calf alkaline phosphatase. After ligation with 100 units, T4 DNA ligase, transform E. coli ZE392 cells and selection of ampicillin-resistant colonies receive nine-ten colonies. Plasmid mini-preparations are prepared from twelve colonies and digested with Hind III to determine the size of the recombinant plasmid and Sma I to determine the correct inclusion of the fragment. One plasmid with the correct structure denoted pMON113.
    Example 5. Twenty µg of plamid pMON 109 split Eco RI and Bam HI (20 units each, 2 hours) and the Bam HI - Eco RI fragment of 3.4 thousand bases was purified using an NA-45 membrane, 20 µg of plasmid / pMOM 41 cleaves Bam HI and Pvu I | (20 each, 2 h, 37 ° C) and Wat HI - Pvu I fragment with a size of 1.5 thousand osto
    15
    20
    25
    Ignorance is cleared using the NA-45 meme brane.
    20 µg of pMON 113 DNA are cleaved by Pvu I and Eco RI (2 units each, 2 hours, 37 ° C) and the Pvu I - Eco RI fragment of 3.1 thousand bases is purified using an NA-45 membrane. To assemble the plasmid pMOM 120 Eco RI - Pvu I, a fragment of 3.1 thousand, bases of pMOM 113 (1.5 µg) are mixed with 1.5 µg of the fragment of Eco RI - Bam HI with a size of 3.4 thousand bases from pMON 109. After T4 treatment with Pigase (3 units) for 16 hours at 10 ° C. The ligase is inactivated by heating (1 rmin 70 ° C) and 5 units of Bam HI are added. Cleavage is continued for 30 minutes at 37 C and at this time Bam KI endonuclease is inactivated by heating as before. Then, 0.75 µg of Pvu I -Bam HI fragment of 1.5 thousand in size, bases from pMON 41 are added together with T4 DNA ligase (2 units) and fresh ATP to a final concentration of 0.75 mM. The final interaction with the ligase is carried out for 4 hours and the mixture is used to transform E. coli ZE 392 cells, followed by the selection of cells that are resistant to spectinomycin, as previously described, Plasmid mini-preparations from twelve of several thousand colonies. The screenings for plasmids of approximately 8 thousand in size, bases containing single Bam HI and Eco RI sites. One plasmid that had the desired structure is designated pMON120, pMON 120 DNA is prepared as in Example 1.
    An E. coli culture containing pMON 120 is deposited in the American Type Culture Collection and assigned a registration number 39263,
    Example 6. Plasmid pMON 75 contains the chimeric NOS-NPTII-NOS gene. This plasmid and pMON 128 are cleaved with the Eco RI and a 1.5 thousand base fragment containing the NOS-MPTII-NOS gene is purified.
    . .50
    Plasmid pMOC 120 is cleaved by Eco R1
    and treated with calf alkaline phosphatase. After phenol deproteinization and precipitation with ethanol Eco RI, split off pMON 120, linear DNA is mixed with 0.5 µg of 1.5 thousand in size, bases Eco RI with a chimerical gene fragment pMON 75 or 76. The resulting mixture is treated with 2 units. T4 DNA
    thirty
    35
    40
    45
    five
    0
    five
    0
    0
    five
    0
    five
    ligases for 1 hour at 220 ° C. After transformation of E. coli cells and selection of spectinomycin-resistant colonies (50 µg / ml), several thousand colonies are revealed. Six of these are selected, grown and plasmid mini-preparations are prepared, Plasmid DNAs are digested with Eco RI to check for the inclusion of a chimerical gene with a size of 1.5 thousand bases and Bam HI to determine the orientation of the inclusion. Bam HI cleavage showed that in the pMOM 128 plasmid, the chimeric gene is transcribed 1 Ј in the same direction as the intact pMOM 120 nopaline synthase gene. E. coli culture, containing pMON 128, is deposited in the American Type Culture Collection and assigned registration number 39264. The orientation of the insert in pMON 129 is opposite to the orientation in pMON 128, the appearance of an additional Bam HI fragment of 1.5 thousand in size, the bases of Bam HI in splitting the plasmid pMON 129, indicates that the plasmid pKON 129 carries tandem duplication of chi, meric NOS -NPT II-NOS gene .
    Example 7. The pMON 128 plasmid was transferred to the Agrobacterium tumefaciens chloramphenic-resistant GV 3111-C58C1 strain carrying the plasmid pTi B65 3 Ti using the crossing technique on the plate of three parents, as follows. ml of E. coli culture carrying pMON 128 ,, mixed with 0.2 ml of culture E, coli strain HB101, carrying the 2013 pRK plasmid and 0.2 ml of GV 311 cells. The resulting mixture of cells is cultured in Luria broth (LB) placed on an LB plate and incubated for 16-24 hours at 30 ° C to allow plasmid transfer and the formation of cointegrative plasmids to be carried out. The cells are resuspended in 3 ml of 10 mM MgSO q . and then a 0.2 ml aliquot is distributed on an LB plate containing 25 µg / ml of chloramphenicol and 100 µg / ml of spectinomycin and streptomycin each. After incubation for 48 hours at 30 ° C, approximately 10 colonies are obtained. One colony is selected and grown at Sp ° C in LB medium. containing chloramphenicol, spectinomycin and streptomycin in the above concentrations,
    A separate type of cointegrating plasmid is prepared for use in
    control experiment by incorporating pMON 120 into A, tumefaciens cells and selecting cells with cointegrative plasmids using spectinomycin and streptomycin. Similar to pMON 120, these plasmids do not contain the chimeric NOS-NPT-II-NOS gene.
    Example 8. Solutions that
    used in the cultivation of plant cells,
    The applicants used the following
    Solutions per 1 liter.
    Enzyme Blend15
    Cellulisin5 g
    Makerozym 0.7 g
    Ampicillin0,4
    KH2P0427.2 mg
    KM0310120
    CaC12
    MgS (7 H2 O KI
    CuS04- 5 Н20 Mannitol MS9 MS Salt Sucrose Vitamins B5 Mannitol
    Phytohormones Benziladine (RA) 2,4-D
    S - ES MS Sucrose Salt Vitamins B5
    1.48 g 246 mg 0.16 mg 0.025 for 110 g25
    4.3
    30.0 g 1 ml 90.0 g
    thirty
    0.5 mg 1 mg 4.3 g 30 g 1 ml
    35
    Mannitol 30g
    Carbenicillin 10 mg
    Phytohormones Indoluxusna
    acid 0.1 mg
    SO MS salt4.3 g
    Sucrose 30.0 g
    Vitamins B51 ml Nutrient medium plates
    MS salt.4.3 g
    Sucrose 30.0 g
    B51 ml vitamins
    Mannitol30.0 g
    Phytohormones
    BA0.5 mg
    S 2C MS salt4.3 g
    Sucrose30 g
    B51 ml vitamins
    Phytohormones Chlorphenoxyacetic
    acid2 mg
    S 104 MS salt4.3 g
    Sucrose 30.0 g
    B51 ml vitamins
    s
    ten
    15
    20
    25
    thirty
    35
    40
    45
    50
    five
    Phytohormones
    BA0.1 mg
    NAA1 mg
    MS 11 MS Salt4.3 g
    Sucrose 30.0 g
    B51 ml vitamins
    Phytohormones Zeatin1 mg
    Sources of vitamin B5 Myoinositol100 g
    Thiamine HC110 g
    Nicotine
    acid1 g
    -, Pyrodoxin HC11 g
    Wash composition MS salt0.43 g
    Sucrose 171.2 g
    PVP - 4040.0 g
    The MS salt comes in the form of a premix as a dry powder.
    Example 9 Mitchell petunia plants are grown in growth chambers with two or three groups of fluorescent lamps and two groups of incandescent lamps (about 5000 lux). The temperature is kept constant at 21 ° C and the plants are illuminated for 12 hours a day. Plants are grown in a mixture of 50/50 vermiculite and PM on a mixture. Plants are watered once a day with Hoagland's nutrient solution. Fabrics are taken from dark green plants with compact bushy growth. The leaf is sterilized in a solution of 10% commercial bleach and a small amount of Tween 20 detergent for 20 minutes with occasional stirring. Leaf moistened; two or three times in distilled water. Thin strips (about 1 mm) are cut out of the leaves perpendicular to the main vein. The strips are placed in a mixture of enzymes taken in relation to about 1 g of tissue per 10 ml of enzymes. The cups are sealed with parafilm and incubated in the dark or in a weak scattered light, while continuously gently mixed (about 40 rpm) on a rotary shaker. The incubation with enzymes is usually carried out overnight, i.e. about 16-20 hours
    The split mixture is sieved through sieves 68, 74 and 88 mesh to remove coarse fragments and hardwood material. The filtrate is centrifuged at 70-100 g for 5 minutes to form protoplast conglomerates. Supernatant
    The liquid is decanted and the flakes are carefully re-suspended in the washing solution. This suspension is drunk in Babcock bottles. Skly nki filled 2-3 cm above the base of the neck. 1 ml of MS9 plant media is carefully placed in a layer on top of the wash solution.
    The Babcock skly will be balanced and the prices trifled at 500-1000 rpm for 10-2D minutes. The protoplasts form a compact strip in the neck at the interface. This strip is removed with a pipette, taken as a precaution not to grab excess solution. Protoplasts are diluted with MS9. At this point, the protoplasts are washed with MS9 or diluted for culture without washing.
    Protoplasts are suspended in MS9 medium to 5 x 10 per ml and placed in T-75 flasks of 6 ml per flask. The flask is incubated at the surface level with weak scattered light or in the dark at 26-28 ° C. On the third day after removing the enzymes from the leaf tissues, MSO (medium that does not contain mannitol) is added to each flask using an amount equal to half of the original volume. The same amount of MSO medium is added again on day 4. This reduces the concentration of mannitol to about 0.33 M after the first dilution and to about 0.25 M after the second dilution.
    Example 10. Fifth day. After protoplast isolation, five-day-old tobacco suspension tobacco cultures (TXD cells) are diluted with MS2C, if necessary, with medium to a point where 1 ml is easily distributed over the surface of agar medium B 100 x 15 mm Petri dishes, i.e. up to 10-15% of suspension (w / v) “Agar medium is prepared by mixing 0.8% agar with MS-ES, processing the mixture in an autoclave and cooling until it hardens in the cups. One ml of TXD suspension is spread on a nutrient medium (25 ml), 8.5 cm disk of Whatman filter paper is placed on TCD cells and smoothed. 7 cm disc of the same paper is placed in the center of a larger disc.
    Separately, aliquots of cell culture of A, tumefaciens cells are added to the bottles that contain plant cells. One set of aliquots
    g 0
    50 ,
    d
    0
    five
    clock contains cells with pMON 128: Ti cointegrative. plasmids containing chimeric NOS-NPT II-MOS g genes. Another set of aliquots contains cells with pMON 120: Ti for integrative-plamides that do not contain the chimerical NOS-APT II-NOS gene.
    Bacteria are added to the flasks at a density of 10 cells / ml. 0.5 ml of the cell mixture is distributed in a thin layer on the surface of a 7 cm disc of filter paper. The plates are then sealed with steam or plastic bags and incubated with no more than 5 plates in direct fluorescent illumination per stack.
    After 7 days, the colonies became visible. After 14 days 7 cm, discs with colonies adhering to them are transferred to a new MSO agarose medium (without feeder cells) containing 500 µg / ml of carbenicillin, as well as 50 µg / ml of canamycin sulfate. After two weeks, intensively growing green colonies are observed on plates that contain plant cells co-cultured with A. tumefaciens strains containing the cointegrative NOS-NPT II gshasmidu pMON 128. Transformed colonies that contain plant cells are not observed on the plates co-cultured with A, tumefaciens strains containing the co-integrative plasmid pMON 120. Kanamycin-resistant transformants maintain growth in culture medium containing kanamycin. Southern's experiments confirm that these cells contain the chimerical NOS-NPT II gene.
    Both sets of transformed cells (and a third set of cells that were transformed in the same way by the chimeric gene encoding an NPT type 1 enzyme) are examined for kanamycin resistance.
    Example 11 Transformed kanamycin-resistant colonies contain both tumor and non-tumor cells. Non-tumor transformed cells are separated from transformed tumor cells and the regeneration of differentiated plant tissues is carried out from non-tumor cells,
    I;
    Colonies are grown on MS 104 agar medium containing 30 μg / ml
    kanamycin sulfate and 500 µg / ml carbanicillin, until they reach about 1 cm in diameter, the tumor colonies, which have a slightly paler shade of green and are looser than non-tumor colonies, are removed from the MS 104 medium and placed on MS 11 medium containing 30 μg / ml kanamycin and 500 μg / ml carbenicillin. As the colonies grow, those that were pale green and had a loose structure are removed and discarded.
    MS11 medium contains zeatin, a phyto-hormone that causes spontaneous formation of sprouts in non-tumor cat Loni x, they show several growths
    15
    权利要求:
    Claims (1)
    [1]
    Invention Formula
    The method of obtaining transformed cells of dicotyledonous plants by co-cultivation of plant cells and Agrobacterium tumefaciens bacteria, o. In order to increase the yield of normal transformed plant cells, the plasmid pMON 128 was constructed by incorporating the antibiotic resistance gene into the pmon 120 vector, the resulting plasmid was introduced into the Agrobacterium tumefaciens GV 3111-C58 Cl / pTi strain B65 3 tra by conjugate virus Escherichia coli / pMON 128, Escherichia coli HB 101 pRK 2013 and AgrobacteKOB bacterial strains, which develop from kanamycin-resistant 20 tumefaciens CV 3111, are selected for dry colonies. These sprouts grow the A. tumefaciens bacteria strain with KdHH to the desired size and are cut with the pGON 128 plasmid with a sharp plasmid: pTi
    blade, and then injected into agarose V65 3 trac on selective medium, concentrated without phytohormones, for example MSO,. holding 25 µg / ml chloramphenicol and where they could develop roots. When 25 by 1p ° µg / ml of spectinomycin and streplenage, the medium is supplemented with naphthalene acetic acid in order to cause the formation of roots. Plants are grown to the desired size in an agarose medium and then transferred to the soil. With proper care, plants grow to maturity and produce seeds.
    Invention Formula
    The method of obtaining transformed cells of dicotyledonous plants by co-cultivation of plant cells and Agrobacterium tumefaciens bacteria, o. In order to increase the yield of normal transformed plant cells, the plasmid pMON 128 was constructed by incorporating the antibiotic resistance gene into the pmon 120 vector, the resulting plasmid was introduced into the Agrobacterium tumefaciens GV 3111-C58 Cl / pTi strain B65 3 tra by conjugate virus Escherichia coli / pMON 128, Escherichia coli HB 101 pRK 2013 and Agrobactetomidine bacterial strains, the antibiotic resistance gene is introduced into plant cells as a result of co-cultivation of protoplasts with A. tumefaciens bacteria containing a co-integrative plasmid and selected was transformed plant cells on selectivity tive medium containing the appropriate antibiotic.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1582990A3|1990-07-30|Method of producing transformed cells of dicetyledonous plant
    EP0131624B1|1992-09-16|Plasmids for transforming plant cells
    JP3098238B2|2000-10-16|DNA assembly, method for inhibiting production of fruit softening enzyme using the same, plant cell containing the DNA assembly, and plant comprising such plant cell
    Kilby et al.1995|FLP recombinase in transgenic plants: constitutive activity in stably transformed tobacco and generation of marked cell clones in Arabidopsis
    FI116067B|2005-09-15|Phosphinotricin resistance gene in plants and its use
    NZ222435A|1990-04-26|Genetic modification of monocotyledonous plants
    WO1984002913A1|1984-08-02|Chimeric genes suitable for expression in plant cells
    WO2005014820A1|2005-02-17|5-enolpyruvyl-3-phosphoshikimate synthase of high glyphosate-bioresistance and coding sequence
    KR970007864B1|1997-05-17|Process of plant which expressing pip of phytolacca insularis nakai
    JP3320064B2|2002-09-03|Use of lysozyme gene structure in plants to increase resistance
    US5831060A|1998-11-03|CPC gene for regulating initiation of root hair formation for arabidopsis | and transgenic |, plant overexpressing the CPC gene
    AU645990B2|1994-02-03|Regulatory DNA sequence
    EP0249432A2|1987-12-16|Transformation and foreign gene expression with plant species
    CN113874501A|2021-12-31|Targeted mutagenesis using base editor
    JP2001190169A|2001-07-17|Transgenic rose plant
    JP2003530888A|2003-10-21|Transgenic plants
    EP0205518A1|1986-12-30|Process for preparing genetically stably transformed monocotyledonous plant cells
    US8334139B1|2012-12-18|Plasmids for transforming plant cells
    JP2574130B2|1997-01-22|Genetic modification of plant cells
    WO1997042315A1|1997-11-13|Transgenic plants resistant to geminivirus infection
    KR101424123B1|2014-08-20|Transgenic colored rice producing capsanthin and the method for producing the same
    KR101229887B1|2013-02-08|Polynucleotide for biosynthesis of beta-carotene and transformed plant using the same
    KR101244025B1|2013-03-14|Recombinant expression vector for rice transformation and Mass manufacturing method for bovine trypsin
    KR20090084014A|2009-08-05|Transformation vector for eliminating selection marker gene
    US20150020238A1|2015-01-15|Plant producing human enterokinase light chain protein and uses thereof
    同族专利:
    公开号 | 公开日
    EP0131620A1|1985-01-23|
    AU2436384A|1984-08-15|
    JPS60500795A|1985-05-30|
    EP0131620A4|1987-09-16|
    AU559562B2|1987-03-12|
    WO1984002920A1|1984-08-02|
    DE3484947D1|1991-09-26|
    US8273954B1|2012-09-25|
    EP0131620B1|1991-08-21|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    RU2451744C2|2006-12-29|2012-05-27|ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи|In vitro methods for induction and maintenance of plant cell lines as single suspension cells with intact cell walls and transformation thereof|US4237224A|1974-11-04|1980-12-02|Board Of Trustees Of The Leland Stanford Jr. University|Process for producing biologically functional molecular chimeras|
    US4652525A|1978-04-19|1987-03-24|The Regents Of The University Of California|Recombinant bacterial plasmids containing the coding sequences of insulin genes|
    DE2942780A1|1979-10-23|1981-05-21|Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen|EUKARYOTIC CELLS, EUKARYOTIC PROTOPLASTICS AND MULTI-CELL EUKARYOTIC LIVING ORGANISMS CONTAINING DNA IN LIPID VESICLES, METHODS FOR THE PRODUCTION OF GENE PRODUCTS, FOR IMMEDIATING, AND DEFECTED BREADING|
    FR2500847B1|1981-03-02|1985-09-13|Pasteur Institut|SELECTIVE GENETIC MARKERS FOR EUKARYOTIC CELLS, METHOD OF IMPLEMENTING SUCH MARKERS AND APPLICATION OF CELLS CONTAINING SUCH A MARKER TO THE MANUFACTURE OF DETERMINED PROTEINS AFTER THEIR TRANSFORMATION WITH A CORRESPONDING DNA|
    US4407956A|1981-03-13|1983-10-04|The Regents Of The University Of California|Cloned cauliflower mosaic virus DNA as a plant vehicle|
    CA1192510A|1981-05-27|1985-08-27|Lawrence E. Pelcher|Rna plant virus vector or portion thereof, a methodof construction thereof, and a method of producing agene derived product therefrom|
    EP0090033A1|1981-10-01|1983-10-05|International Plant Research Institute|Process for the genetic modification of cereals with transformation vectors|
    NL8200523A|1982-02-11|1983-09-01|Univ Leiden|METHOD FOR TRANSFORMING IN VITRO PLANT PROTOPLASTS WITH PLASMIDE DNA.|
    US4436475A|1982-02-16|1984-03-13|Rolligon Corporation|Log skidder with load distributing boom attachment|
    US4459355A|1982-07-12|1984-07-10|International Paper Company|Method for transforming plant cells|
    IL69382A|1982-08-05|1991-01-31|Carter William Alvin|Method of protecting plants against viral pathogens by inserting into plant cells genes encoding polypeptides containing interferon domains|
    US4762785A|1982-08-12|1988-08-09|Calgene, Inc.|Novel method and compositions for introducting alien DNA in vivo|
    US4536475A|1982-10-05|1985-08-20|Phytogen|Plant vector|
    DE3381568D1|1983-01-13|1990-06-21|Max Planck Gesellschaft|METHOD FOR INTRODUCING EXPRESSIVE GENES IN PLANT CELL GENENOMES AND AGROBACTERIUM STEMS CONTAINING HYBRID TI PLASMIDE VECTORS USED IN THIS METHOD.|
    AT52800T|1983-01-13|1990-06-15|Max Planck Gesellschaft|METHOD FOR INTRODUCING EXPRESSIVE GENES IN PLANT CELL GENENOMES AND AGROBACTERIUM STEMS CONTAINING HYBRID TI PLASMIDE VECTORS USED IN THIS METHOD.|
    US6051757A|1983-01-14|2000-04-18|Washington University|Regeneration of plants containing genetically engineered T-DNA|
    WO1984002913A1|1983-01-17|1984-08-02|Monsanto Co|Chimeric genes suitable for expression in plant cells|
    US6174724B1|1983-01-17|2001-01-16|Monsanto Company|Chimeric genes suitable for expression in plant cells|
    US5352605A|1983-01-17|1994-10-04|Monsanto Company|Chimeric genes for transforming plant cells using viral promoters|
    US5034322A|1983-01-17|1991-07-23|Monsanto Company|Chimeric genes suitable for expression in plant cells|
    WO1984002919A1|1983-01-17|1984-08-02|Monsanto Co|Plasmids for transforming plant cells|
    NZ207765A|1983-04-15|1987-03-06|Lubrizol Genetics Inc|Plant expression of transferred dnafrom plasmids associated with agrobacterium sp|
    BR8404834A|1983-09-26|1985-08-13|Agrigenetics Res Ass|METHOD TO GENETICALLY MODIFY A PLANT CELL|
    DK162399C|1986-01-28|1992-03-23|Danisco|PROCEDURE FOR EXPRESSION OF GENES IN BELGIUM PLANT CELLS, DNA FRAGMENT, RECOMBINED DNA FRAGMENT AND PLASMID FOR USE IN EXERCISING THE PROCEDURE|
    US5106739A|1989-04-18|1992-04-21|Calgene, Inc.|CaMv 355 enhanced mannopine synthase promoter and method for using same|WO1984002919A1|1983-01-17|1984-08-02|Monsanto Co|Plasmids for transforming plant cells|
    NL8300699A|1983-02-24|1984-09-17|Univ Leiden|METHOD FOR BUILDING FOREIGN DNA INTO THE NAME OF DIABIC LOBAL PLANTS; METHOD FOR PRODUCING AGROBACTERIUM TUMEFACIENS BACTERIEN; STABLE COINTEGRATE PLASMIDS; PLANTS AND PLANT CELLS WITH CHANGED GENETIC PROPERTIES; PROCESS FOR PREPARING CHEMICAL AND / OR PHARMACEUTICAL PRODUCTS.|
    NZ207765A|1983-04-15|1987-03-06|Lubrizol Genetics Inc|Plant expression of transferred dnafrom plasmids associated with agrobacterium sp|
    NZ207766A|1983-04-15|1987-03-06|Lubrizol Genetics Inc|Plant structural gene expression|
    US5102796A|1983-04-15|1992-04-07|Lubrizol Genetics, Inc.|Plant structural gene expression|
    NZ209338A|1983-09-14|1988-02-12|Lubrizol Genetics Inc|Plasmid for the transformation of a plant cell|
    AT204017T|1984-05-11|2001-08-15|Syngenta Participations Ag|TRANSFORMATION OF PLANT HERITAGE|
    US5231019A|1984-05-11|1993-07-27|Ciba-Geigy Corporation|Transformation of hereditary material of plants|
    JPH0612990B2|1984-08-09|1994-02-23|株式会社アドバンス|Method for increasing CO2 fixation capacity of living cells|
    EP0174166A1|1984-08-31|1986-03-12|Lubrizol Genetics Inc.|Disarmed T-DNA|
    EP0200746B1|1984-10-01|1991-01-30|The General Hospital Corporation|Plant cells resistant to herbicidal glutamine synthetase inhibitors|
    US6281410B1|1986-07-31|2001-08-28|Calgene Llc|Methods and compositions for regulated transcription and expression of heterologous genes|
    US5254799A|1985-01-18|1993-10-19|Plant Genetic Systems N.V.|Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants|
    CA1341290C|1985-05-13|2001-09-11|Thomas Hohn|Method of genetically modifying plants|
    US6774283B1|1985-07-29|2004-08-10|Calgene Llc|Molecular farming|
    US4956282A|1985-07-29|1990-09-11|Calgene, Inc.|Mammalian peptide expression in plant cells|
    FI864720A|1985-11-22|1987-05-23|Ciba Geigy Ag|DIRECTIVE OF THE PLASTIC UNIT AND OF THE MITOKONDRIER.|
    AU611080B2|1986-01-08|1991-06-06|Rhone-Poulenc Agrochimie|Haloarylnitrile degrading gene, its use, and cells containing the same|
    CA1338902C|1986-02-27|1997-02-11|Howard M. Goodman|Plant cells resistant to herbicidal glutamine synthetase inhibitors|
    ES2018274T5|1986-03-11|1996-12-16|Plant Genetic Systems Nv|VEGETABLE CELLS RESISTANT TO GLUTAMINE SYNTHETASE INHIBITORS, PREPARED BY GENETIC ENGINEERING.|
    KR910007612B1|1990-01-10|1991-09-28|한국과학기술연구원|Method for producing of insulin in plant|
    KR910014790A|1990-01-10|1991-08-31|한태희|Function Selection Method and Interface Circuit of Laptop Computer|
    US5767376A|1995-06-07|1998-06-16|University Of Hawaii At Manoa|Nucleic acids encoding a papaya ACC synthase gene|
    IL124020A|1995-10-13|2003-05-29|Dow Agrosciences Llc|Plant optimized nucleotide sequence that encodes an insecticidal crystal protein|
    US6586661B1|1997-06-12|2003-07-01|North Carolina State University|Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid|
    US6096546A|1998-01-30|2000-08-01|Board Of Trustees, Rutgers, The State University Of New Jersey|Methods for recovering polypeptides from plants and portions thereof|
    US6100092A|1998-06-15|2000-08-08|Board Of Trustees, Rutgers The State University Of New Jersey|Materials and methods for amplifying polynucleotides in plants|
    US6544789B1|2000-03-13|2003-04-08|Board Of Trustees, Rutgers, The State University Of New Jersey|Phosphorus-controllable recombinant expression of polypeptides in plants|
    WO2002100199A2|2001-06-08|2002-12-19|Vector Tobacco Ltd.|Modifying nicotine and nitrosamine levels in tobacco|
    US9133475B2|2008-11-26|2015-09-15|Board Of Trustees Of Michigan State University|Aphid resistant soybean plants|
    CA2608717A1|2005-05-18|2006-11-23|The Board Of Trustees Operating Michigan State University|Resistance to soybean aphid in early maturing soybean germplasm|
    WO2012064827A1|2010-11-11|2012-05-18|Purdue Research Foundation|Methods and compositions to regulate plant transformation susceptibility|
    CA2836403A1|2013-01-04|2014-07-04|Board Of Trustees Of Michigan State University|New sources of aphid resistance in soybean plants|
    BR112018004108A2|2015-08-28|2018-12-11|Du Pont|isolated ochrobactrum haywardense h1, ochrobactrum hawardward h1, method for producing a transformed plant cell, kit and vector|
    US10894812B1|2020-09-30|2021-01-19|Alpine Roads, Inc.|Recombinant milk proteins|
    US10947552B1|2020-09-30|2021-03-16|Alpine Roads, Inc.|Recombinant fusion proteins for producing milk proteins in plants|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US45840283A| true| 1983-01-17|1983-01-17|
    [返回顶部]